EXOSOME DIAGNOSTICS INC
EXOSOME DIAGNOSTICS INC is a federal contractor, registered under UEI TCKUCULVVY39 and CAGE code 554U8. It has been awarded $3,928,284 in federal contracts. Primary work spans Unknown NAICS and Medical Laboratories. Top awarding agencies include Department Of Health And Human Services (hhs), Department Of Veterans Affairs, and Other agencies (1 agencies, <0.5% each).
Contact Information
Registration and classification details
Registration
UEI Code
TCKUCULVVY39CAGE Code
554U8Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
Exosome Diagnostics Inc. specializes in advanced molecular diagnostics for prostate cancer, delivering precision genomic testing services through its EXODX Prostate IntelliScore platform. The company provides clinically validated liquid biopsy assays that analyze exosomal RNA biomarkers to aid in ri...
Exosome Diagnostics Inc. specializes in advanced molecular diagnostics for prostate cancer, delivering precision genomic testing services through its EXODX Prostate IntelliScore platform. The company provides clinically validated liquid biopsy assays that analyze exosomal RNA biomarkers to aid in risk stratification and reduce unnecessary biopsies, enabling personalized clinical decision-making for urologic oncology. Their technical expertise lies in next-generation sequencing data interpretation, biomarker validation, and laboratory-developed test (LDT) deployment within high-compliance clinical environments. Key differentiators include rapid turnaround for urgent clinical needs, seamless integration with VA pathology workflows, and a focused portfolio centered on non-invasive prostate cancer detection. The contractor maintains a consistent, long-standing relationship with the Department of Veterans Affairs, serving multiple VA medical centers with diagnostic testing for prostate cancer evaluation. Work includes both routine and emergency-order testing for biopsy decision support, demonstrating reliable operational responsiveness to time-sensitive clinical requirements. The recurring nature of these engagements reflects trusted, embedded service delivery within VA’s urology and pathology networks. Exosome Diagnostics operates primarily under NAICS 621511, which encompasses clinical laboratory services for diagnostic testing. The company is specialized in precision oncology diagnostics, positioning itself at the intersection of molecular diagnostics and veteran healthcare. Its market focus is narrow but deep, targeting the growing demand for non-invasive cancer screening tools in institutional care settings. As a small business structured as a 2L entity based in Waltham, Massachusetts, Exosome Diagnostics Inc. maintains a focused geographic footprint aligned with federal healthcare procurement. While no formal government certifications are listed, its consistent performance under VA contracts indicates adherence to CLIA, CAP, and other clinical laboratory quality standards essential for federal healthcare delivery.
Key Performance Metrics
Awards Count
27
All time
Active
6
Currently performing
Completed
21
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with EXOSOME DIAGNOSTICS INC
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for EXOSOME DIAGNOSTICS INC
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
